THE USE OF CUPPING THERAPY IN REDUCING CVD RISK FACTORS

Slides:



Advertisements
Similar presentations
Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment  Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.
Advertisements

The Healthy Heart Figure 14.1.
Hemostasis & Thrombosis: Platelet Disorders Beth A. Bouchard BIOC 212: Biochemistry of Human Disease Spring 2005.
CVD prevention & management: a new approach for primary care Rod Jackson School of Population Health University of Auckland New Zealand.
Overcoming the challenge of blood pressure control in prediabetic and diabetic patients: PICASSO T2D Study Efficacy and tolerability of fixed dose combination.
Canadian Diabetes Association Clinical Practice Guidelines Dyslipidemia Chapter 24 G. B. John Mancini, Robert A. Hegele, Lawrence A. Leiter.
Special Diabetes Program for Indians Competitive Grant Program SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program Clinical Goals for the Healthy.
Effectiveness of interactive web-based lifestyle program on prevention of cardiovascular diseases risk factors in patient with metabolic syndrome: a randomized.
BHS Guidelines for the management of hypertension BHS IV, 2004 and Update of the NICE Hypertension Guideline, 2006 Guidelines for management of hypertension:
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
By Cyneetha Strong, MD May 19,  Diseases and conditions pertaining to the heart and vascular (blood vessels) system  Primarily includes heart.
Exercise the Medicine of Choice Reducing Cardiovascular Risk Dr. Lynn Panton Florida State University College of Human Sciences Department of Nutrition,
Effects of Low-Fat Dairy Consumption on Markers of Low- Grade Systemic Inflammation and Endothelial Function in Overweight and Obese Subjects: An Intervention.
©2007 RUSH University Medical Center Hyperuricemia in adolescents with primary hypertension: how and when to intervene? Farahnak Assadi, M.D. Professor.
Management of Dyslipidemia in Patients with Peripheral Arterial Disease: an update from Guidelines Oman International Vascular Conference Al-Bustan Palace.
METABOLIC SYNDROME Dr Gerhard Coetzer. Complaint Thirsty all the time Urinating more than usual Blurred vision Tiredness.
Lower levels of ADAMTS13 are associated with cardiovascular disease by Supakanya Lasom Master Degree Student of Medical Sciences, Bongers T.N, Bruijne.
The effects of initial and subsequent adiposity status on diabetes mellitus Speaker: Qingtao Meng. MD West China hospital, Chendu, China.
SERUM VISFATIN CONCENTRATION IS ASSOCIATED WITH AN ATHEROGENIC METABOLIC PROFILE T.D. Filippatos 1, A. Liontos 1, F. Barkas 1, E. Klouras 1, V. Tsimihodimos.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
TREAT TO TARGET IN DIABETES: An Alternative pathway
1 The Study of Trandolapril- verapamil And insulin Resistance STAR determined whether glycaemic control was maintained to a greater degree by an RAS inhibitor/non-DHP.
TEMPLATE DESIGN © Diet Plus Insulin Compared to Diet Alone In The Treatment of GDM Mothers in HUSM, Kelantan. Wan Faizah.
1. Relation between dietary macronutrient and fiber intake with metabolic syndrome in Tehranian adults: Tehran Lipid and Glucose Study Hosseinpour S,
Conclusion In conclusion, preliminary data from this nutrition intervention study suggest that a well balanced Mediterranean-type diet is able to reduce.
The Effect of Chocolate Consumption on Cardiovascular Disease Risk Factors Stephanie Becker November 24, 2014.
* Indicates p < 0.05 indicates p < 0.05 Evaluating Clinical Pharmacist Impact on Diabetes Control* Mary Ella Hill, Pharm. D. Candidate; Orijane Dalton,
Association between Systolic Blood Pressure and Congestive Heart Failure Complication among Hypertensive and Diabetic Hypertensive Patients Mrs. Sutheera.
Company LOGO EFFECTS OF GARLIC ON CARDIOVASCULAR DISEASE PARAMETERS BY FAROUK EL-SABBAN AND ZORIAH AZIZ 1 MSPP MEETING - KUALA LUMPUR April 5, 2008 Department.
European Union Garlic Inflammation Study (EUGIS) in Humans Martijn van Doorn Sonia Espirito Santo TNO-PH Leiden The Netherlands CHDR Leiden The Netherlands.
atherosclerosis Jon Yap John A. Burns School of Medicine
2Haemophilia Department, Royal Free Hospital, London, United Kingdom
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
Von Willebrand Disease
The Effects of Brisk Walking on Biochemical Risk Factors and Functional Capacity in Healthy, Sedentary 50 to 65 Year Old Patients of Primary Care M.Tully.
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Lab 6 TC, LDL-C, HDL-C, and TG T.A. Bahiya Osrah
Dr. Nadira Mehriban. INTRODUCTION Diabetic retinopathy (DR) is one of the major micro vascular complications of diabetes and most significant cause of.
prepared by Dr. Akaber Tarek Biochemistry Department Clinical Chemistry prepared by Dr. Akaber Tarek Biochemistry Department Clinical Chemistry prepared.
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
The Influence of Pravastatin and Atorvastatin on Markers of Oxidative Stress in Hypercholesterolemic Humans Bonnie Ky, MD,* Anne Burke, MD,* Sotirios Tsimikas,
Circulation. 2014;129: Association Between Plasma Triglycerides and High-Density Lipoprotein Cholesterol and Microvascular Kidney Disease and Retinopathy.
Changes in the concentration of serum C-peptide in type 2 diabetes during long-term continuous subcutaneous insulin infusion therapy Department of Internal.
METHODS INTRODUCTION I Webster, C Westcott, C Marincowitz, N Mashele, P De Boever, N Goswami, H Strijdom Division of Medical Physiology, Faculty of Medicine.
Baseline characteristics of HPS participants by prior cerebrovascular disease.
Powered by Infomedica Infomedica Conference Coverage* of 26 th European Meeting on Hypertension and Cardiovascular Protection Paris (France), June 10-13,
Dr John Cox Diabetes in Primary Care Conference Cork
Venous Thromboembolism-1
Title slide.
Heart Intervention Lesson 4.4.
Baseline characteristics and effectiveness results
Arabinda Mohan Bhattarai, MBBS, MD (Biochemistry) Asst Prof, NAIHS
Evaluation of Vascular Resistance in the Intracerebral and Extracerebral Arteries in Patients with Diabetes Mellitus type 1 - preliminary results Author:
Dr. Syed Waleem Pasha Assistant Professor Yenepoya Medical College
Prevalence Of Metabolic Syndrome And Assessment Of Nutritional And Biochemical Parameters Of Overweight And Obese Working Women 1Upasana, 2Chakravarty.
Serum ceruloplasmin, copper, zinc levels and Cu/Zn ratio in malignancy
Serum soluble fms like tyrosine kinase-1(sflt-1)
by Sarah Steinmetz and Amber Brouillette
Comparison of baseline characteristics in participants who subsequently had an incident cardiovascular event or new-onset diabetes in the Prospective.
PS Sever, PM Rothwell, SC Howard, JE Dobson, B Dahlöf,
The pathology of cardiovascular disease (CVD)
Baseline characteristics of HPS participants by prior diabetes
Unit 4.4 Review PBS.
The results of the SHARP trial
10-B Blood.
Lipid-Lowering Arm (ASCOT-LLA): Results in the Subgroup of Patients with Diabetes Peter S. Sever, Bjorn Dahlöf, Neil Poulter, Hans Wedel, for the.
The child with hematological dysfunction
DENERHTN Trial design: Patients with resistant hypertension were randomized to renal denervation plus standardized stepped-care antihypertensive treatment.
The results of the SHARP trial
PROSPER: trial design                                                                                                                                                                 
Presentation transcript:

THE USE OF CUPPING THERAPY IN REDUCING CVD RISK FACTORS PROF. DR AB AZIZ AL-SAFI ISMAIL USM, KELANTAN, MALAYSIA (2nd International Conference on Quality Propathic Medicine, Jeddah 5-7 April 2016) 1

EVIDENCE-BASED MEDICINE

HONEY & CUPPING Narrated Ibn `Abbas: (The Prophet ﷺ) ) said, "Healing is in three things: A gulp of honey, cupping, and branding with fire (cauterizing)." But I forbid my followers to use (cauterization) branding with fire." (Sahih al-Bukhari)  

CUPPING "‏ مَا مَرَرْتُ لَيْلَةَ أُسْرِيَ بِي بِمَلإٍ مِنَ الْمَلاَئِكَةِ إِلاَّ كُلُّهُمْ يَقُولُ لِي عَلَيْكَ يَا مُحَمَّدُ بِالْحِجَامَةِ ‏" It was narrated from Ibn ‘Abbas that the Messenger of Allah (ﷺ ) said: “On the night on which I was taken on the Night Journey (Isra’), I did not pass by any group of angels but all of them said to me: ‘O Muhammad, you should use cupping.” (Sunan Ibn Majah)

CUPPING ‏ "‏ إِنْ كَانَ فِي شَىْءٍ مِمَّا تَدَاوَيْتُمْ بِهِ خَيْرٌ فَالْحِجَامَةُ ‏"‏ ‏.‏ Narrated Abu Hurairah: The Prophet (ﷺ) said: The best medical treatment you apply is cupping. (Sunan Abi Dawud, Sunan Ibn Majah)  "‏ مَنِ احْتَجَمَ لِسَبْعَ عَشْرَةَ وَتِسْعَ عَشْرَةَ وَإِحْدَى وَعِشْرِينَ كَانَ شِفَاءً مِنْ كُلِّ دَاءٍ ‏"‏ ‏ Narrated Abu Hurairah: The Prophet (ﷺ) said: If anyone has himself cupped on the 17th, 19th and 21st it will be a remedy for every disease. (Sunan Abi Dawud)

POINT OF UMMU MUGHITS Narrated `Abdullah bin Buhaina: Allah's Messenger (ﷺ) was cupped on the middle of his head at Lahl Jamal on his way to Mecca while he was in a state of Ihram. (Sahih al-Bukhari) Narrated Abu Hurairah: Abu Hind cupped the Prophet (ﷺ) in the middle of his head. The Prophet (ﷺ) said: Banu Bayadah, marry AbuHind (to your daughter), and ask him to marry (his daughter) to you. He said: The best thing by which you treat yourself is cupping. (Sunan Abi Dawud) aziz.alsafi@usm.my

POINT OF QOMAHDUWAH The Prophet ((ﷺsaid “Use cupping on the nape cavity for it is cure for seventy-two diseases” [Recorded by At-Tabarani] Abu Nu'aim, in his book Al-Tibb al-Nabawî aziz.alsafi@usm.my

BIOCHEMICAL AND HEMODYNAMIC PARAMETERS A randomized control trial was done among 47 healthy people in Iran to look for the effect of cupping on lipid concentration. Serum lipid was taken before cupping and once a week for 3 weeks. There were decrease in LDL cholesterol (p < 0.001) and in the LDL/HDL ratio (p < 0.001) was found in the treated group compared to the control (Niasari et al., 2007).

There was significant changes in A study in Pakistan among 25 healthy male subject, to compare the venous blood and the cupping blood. There was significant changes in Serum cholesterol, triglyceride, HDL, LDL Serum urea and serum creatinine Blood sugar (Bilal et al.,2011) A pilot study of cupping as adjunctive therapy in the treatment of diabetes, hypertension and osteoarthritis was done at University of Western showed that the blood glucose was significantly reduced after the cupping therapy (p<0.001) (Bhika, 2008).

USM STUDY PROBING THE WET CUPPING THERAPY ON MEASURABLE BENEFICIAL HEALTH EFFECTS OBJECTIVE To study the effect of wet cupping therapy on anthropometrics, biochemical, hemodynamic parameters and microvascular endothelial function on healthy individual

Methodology

Study place USM Kubang Kerian, Kelantan, Malaysia Study period January 2011 – February 2014

FLOW CHART

31 subjects for each group Study subject For Phase 1 Cupping group among healthy individual Control group Sample size 31 subjects for each group

Criteria For Study Subject Inclusion criteria Age 30 to 55 years old Healthy Exclusion criteria On medication Pregnant women Chronic disease History of blood disorder (eg hemophilia) On anti-coagulant medication Being treated for cancer History of allergy to latex History of stroke Patient with hepatitis and HIV

Instrumentation Basic cupping therapy equipment : Hand suction pump Plastic cups Lancet pen Antiseptic tools

The Procedure The Wet Cupping Technique (Ahmadi et al., 2008) Wet cupping was performed using transparent plastic vacuum cups. Cupping was done at five different sites Both scapula Both lumbar region Vertex

The Prophet’s 10 cupping points

STEP 1 Procedure was done using aseptic technique. Area around the cupping site was cleaned using an antiseptic preparation (NICE, 2008). aziz.alsafi@usm.my

STEP 2 The cups were placed on the respective points using a hand suction pump The local suction created allowed the skin and superficial muscle layer to be lightly drawn into the cups. The cups were left for a period of 8-10 minutes. aziz.alsafi@usm.my

STEP 3 A lancet pen was used to prick the skin at different sites around the cupped area (Abdullah, 1995) aziz.alsafi@usm.my

STEP 4 A hand suction pump is used to create vacuum underneath the cup aziz.alsafi@usm.my

STEP 5 Once the blood from that area stopped collecting, the cups were removed and the blood safely discarded. The skin area was then cleaned. (Manz, 2009 and Chirali, 1999) aziz.alsafi@usm.my

Results

Variables Cupping group Control group Age 44.97 (6.44) 43.23 (7.39) Table 1 : Socio-demographic characteristics of study subject Variables Cupping group Control group Age 44.97 (6.44) 43.23 (7.39) Gender Female Male 24 (45.2) 17 (54.8) 21 (67.7) 10 (32.3)

Comparison of Biochemical Parameters Between Cupping, Control Group and Diabetic Group

TOTAL CHOLESTEROL Changes of Total cholesterol level in diabetic group Comparison of Total cholesterol level in both groups There were significant differences of total cholesterol level between cupping, control group and diabetic groups at month 3 and month 4

HDL- CHOLESTEROL Changes of serum HDL-C level in diabetic group Comparison of HDL-C level in both groups There were significant differences of serum HDL-C level between cupping and control group at month 3 and month 4

LDL- CHOLESTEROL Changes of serum LDL-C level in diabetic group Comparison of LDL-C level in both groups There were significant differences of serum LDL-C level between cupping and control group at month 3 and month 4

TRIGLYCERIDES Comparison of Triglycerides level in both groups Changes of serum triglycerides level in diabetic group There were significant differences of triglycerides level between cupping and control group at month 4 There was no significant differences of serum triglycerides level

FASTING BLOOD SUGAR Comparison of fasting blood sugar level in both groups Changes of fasting blood sugar in diabetic group There were significant differences of fasting blood sugar level between cupping, control group and diabetic group at month 4

SERUM UREA Changes of serum urea level in diabetic group Comparison of serum urea level in both groups There were significant differences of serum urea level between cupping, control group and diabetic group at month 4

SERUM CREATININE Changes of serum creatinine level in diabetic group Comparison of serum creatinine level in both groups There were significant differences of serum creatinine level between cupping, control group and diabetic group at month 4

SERUM URIC ACID Comparison of serum uric acid level in both groups Changes of serum uric acid level in diabetic group There was no significant difference of serum uric acid level between cupping and control group There were significant differences of serum uric acid level at: Baseline – month 1 Baseline – month 3 Baseline – month 4

CUPPING THERAPY IMPROVE ENDOTHELIAL FUNCTION Antigen Von Willebrand factor (VWF) Profile plot shows estimated marginal mean of von Willebrand factor antigen for cupping and control group.

CUPPING THERAPY IMPROVE ENDOTHELIAL FUNCTION Antigen Von Willebrand factor (VWF) Profile plot shows estimated marginal mean of von Willebrand factor for diabetic group.

VON WILLEBRAND FACTOR The vWF is a high molecular weight plasma protein, produced by endothelial cells and megakaryocytes which circulates in the blood plasma and its functions is to promote adhesion of platelets to collagen in hemostatic plug formation (Verma S et al., 2003). Patients with microvascular dysfunction shows high level of vWF expression (Hallenbeck J. M et al., 1981; Dash S et al., 1995) which also indicates severe damage to the microvasculature system in astrocytic glioma patients. (Hillen et al., 2007) vWF- glycoprotein is essential for normal hemostasis that is involved in the inflammatory process, and the regulation of angiogenesis (Starke et al., 2011).

VON WILLEBRAND FACTOR The von Willebrand factor (vWF) is principally released by endothelial cells and mediates the initiation and progression of thrombus formation via platelet aggregation at a site of vascular injury. (Spiel et al., 2008). Other studies have indicated that VWF is a mediator for platelet adhesion to the vessel wall and for platelet-platelet interactions under high shear-stress conditions (Rumbaut et al.,2010) Moreover, prolonged and/or repeated exposure to cardiovascular risk factors can ultimately exhaust the protective effect of endogenous anti-inflammatory systems within endothelial cells. As a consequence, the endothelium not only becomes dysfunctional, but the endothelial cells can also lose their integrity, resulting in senescence and detached into the circulation (Woywodt  et al., 2008)

SYSTOLIC BLOOD PRESSURE Profile plot shows estimated marginal mean of SBP for cupping and control group. Profile plot shows estimated marginal mean of SBP for diabetic group There were significant reduction of SBP between cupping, control group and diabetic group at month 4

DIASTOLIC BLOOD PRESSURE Profile plot shows estimated marginal mean of DBP for cupping and control group. Profile plot shows estimated marginal mean of DBP for diabetic group There were significant reduction of DBP between cupping, control group and diabetic group at month 4

Conclusions In both normal and diabetic group, there were significant improvements of: Serum lipid profile (total cholesterol, HDL-C, LDL-C and triglycerides) Fasting blood sugar Renal functions (serum urea, creatinine, uric acid) VWF, SBP & DBP

CUPPING THERAPY PREVENTIVE CURATIVE

APPRECIATION MOSTI UNIVERSITI SAINS MALAYSIA SCHOOL OF MEDICAL SCIENCES HEADS OF DEPARTMENTS ORGANISING COMMITTEE aziz.alsafi@usm.my

COURSE & BOOK

PUBLICATIONS THE EFFECT OF WET CUPPING THERAPY (BEKAM) ON FASTING BLOOD SUGAR IN HEALTHY INDIVIDUAL : A RANDOMIZED CONTROLLED TRIAL Suhaily Mohd Hairon, Ab Aziz al-Safi Ismail, Najib Majdi Yaacob, Nik Rosmawati Nik Hussain, Rehanah Mohd Zain, Mujahid Bakar, THE EFFECT OF WET CUPPING ON SERUM LIPID PROFILE IN HEALTHY INDIVIDUAL Suhaily Mohd Hairon, Abdul Aziz al-Safi Ismail, Nik Rosmawati Nik Hussain, Mohamed Saat Ismail, Rehanah Mohd Zain, Mujahid Bakar, Najib Majdi Yaacob THE EFFECT OF WET CUPPING THERAPY (BEKAM) ON RENAL FUNCTION TEST IN HEALTHY INDIVIDUAL Suhaily Mohd Hairon, Ab Aziz al-Safi Ismail, Najib Majdi Yaacob, Nik Rosmawati Nik Hussain, Rehanah Mohd Zain, Mujahid Bakar, RANDOMIZED CONTROL TRIAL STUDY ON THE EFFECT OF WET CUPPING ON SERUM LIPID PROFILE Suhaily Mohd Hairon, Ab Aziz Al-Safi Ismail, Nik Rosmawati Nik Hussain, Najib Majdi Yaacob, Mohamed Saat Ismail, Rehanah Mohd Zain, Mujahid Bakar

Thank You